Suppr超能文献

MRI 检测到的外突静脉侵犯、中低位直肠癌系膜延伸和淋巴结状态对临床 T3 期直肠癌的预后意义。

The prognostic significance of MRI-detected extramural venous invasion, mesorectal extension, and lymph node status in clinical T3 mid-low rectal cancer.

机构信息

Department of Gastrointestinal Surgery, West China Hospital, Sichuan University, No. 37 Guo Xue Alley, Chengdu, 610041, Sichuan Province, China.

Department of Radiology, West China Hospital, Sichuan University, No. 37 Guo Xue Alley, Chengdu, 610041, Sichuan Province, China.

出版信息

Sci Rep. 2019 Aug 29;9(1):12523. doi: 10.1038/s41598-019-47466-0.

Abstract

The purpose of this study was to evaluate the prognostic significance of the magnetic resonance imaging-detected extramural venous invasion (MR-EMVI), the depth of mesorectal extension (MR-DME), and lymph node status (MR-LN) in clinical T3 mid-low rectal cancer. One hundred and forty-six patients with clinical T3 mid-low rectal cancer underwent curative surgery were identified. Pretreatment high-resolution MRI was independently reviewed by two experienced radiologists to evaluate MR-EMVI score (0-4), MR-DME (≤4 mm or >4 mm), and MR-LN (positive or negative). The Cox-multivariate regression analysis revealed that the MR-EMVI was the only independent prognostic factor that correlated with overall 3-year disease-free survival (DFS) (p = 0.01). The survival analysis showed that patients with positive MR-EMVI, MR-DME > 4 mm, and positive MR-LN had a poorer prognosis in the overall 3-year DFS (HR 3.557, 95% CI 2.028 to 13.32, p < 0.01; HR 3.744, 95% CI:1.165 to 5.992, p = 0.002; HR 2.946, 95% CI: 1.386 to 6.699, p < 0.01). By combining MR-EMVI with MR-DME or MR-LN, the prognostic significance was more remarkable. Our study suggested that the MR-EMVI, MR-DME, and MR-LN were the important prognostic factors for patients with clinical T3 mid-low rectal cancer and the MR-EMVI was an independent prognostic factor.

摘要

本研究旨在评估磁共振成像检测到的外膜静脉侵犯(MR-EMVI)、直肠系膜延伸深度(MR-DME)和淋巴结状态(MR-LN)在临床 T3 中低位直肠癌中的预后意义。我们确定了 146 例接受根治性手术的临床 T3 中低位直肠癌患者。两名经验丰富的放射科医生对术前高分辨率 MRI 进行独立评估,以评估 MR-EMVI 评分(0-4 分)、MR-DME(≤4mm 或>4mm)和 MR-LN(阳性或阴性)。Cox 多因素回归分析显示,MR-EMVI 是唯一与总 3 年无病生存率(DFS)相关的独立预后因素(p=0.01)。生存分析显示,MR-EMVI 阳性、MR-DME>4mm 和 MR-LN 阳性的患者总 3 年 DFS 预后较差(HR 3.557,95%CI 2.028-13.32,p<0.01;HR 3.744,95%CI:1.165-5.992,p=0.002;HR 2.946,95%CI:1.386-6.699,p<0.01)。通过将 MR-EMVI 与 MR-DME 或 MR-LN 相结合,预后意义更加显著。我们的研究表明,MR-EMVI、MR-DME 和 MR-LN 是临床 T3 中低位直肠癌患者的重要预后因素,MR-EMVI 是独立的预后因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddf1/6715653/911a3dc4cf16/41598_2019_47466_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验